ASCO 2022 Conference Coverage


 

Lecture Summary - ASCO 2022 on Multicenter Phase II Study of Abemaciclib & Ramucirumab in Metastatic Esophageal/GEJ Carcinoma

18 views
June 10, 2022
Comments 0
Login to view comments. Click here to Login